Kinetics of Hypericin Association With Low‐Density Lipoproteins

Abstract

Steady-state and time-resolved fluorescence spectroscopy have been used for the study of the incorporation kinetics of hypericin (Hyp) into low-density lipoproteins (LDL). Biphasic kinetics of Hyp association with LDL was observed when solutions of Hyp and LDL were mixed at various concentration ratios. The rapid phase of Hyp incorporation is completed within seconds, while the slow phase lasts several minutes. The relative contributions of the individual phases show that a higher amount of Hyp molecules (65%) are incorporated into LDL in the second phase. The kinetics of the incorporation of Hyp into LDL particles preloaded with Hyp (Hyp/LDL=25:1) was also investigated. The decreased intensity of Hyp fluorescence is a sign of the formation of Hyp aggregates after penetration of additional Hyp molecules into Hyp/LDL=25:1 complex. The time dependence of Hyp fluorescence was measured after mixing the complex Hyp/LDL =200:1 with appropriate amounts of free LDL molecules. For each final Hyp/LDL ratio, an increase in the intensity and lifetime of Hyp fluorescence was observed, suggesting a monomerization of Hyp aggregates. The half-time of Hyp transfer from Hyp/LDL complex to LDL particles is similar to the half-time of the slow phase of Hyp incorporation into free LDL particles.

Unique Diagnostic and Therapeutic Roles of Porphyrins and Phthalocyanines in Photodynamic Therapy, Imaging and Theranostics

“…They are biocompatible, biodegradable and non-immunogenic species that serve as the main vehicle for transporting cholesterol molecules to mammalian cells 6, 119-137, 142-146. Lipoproteins have two main roles: to solubilise highly hydrophobic lipids and regulate the passage of specific lipids into and out of particular cells and tissue.…”

“…Such differences in delivery and localisation properties could be utilised for the desired mode of tumour control: albumin delivery for extracellular tumour cell damage and LDL transport for a more direct cell death mode 135, 141. The binding of photosensitisers to serum proteins is generally determined by photosensitiser hydrophobicity - moderately hydrophobic photosensitisers show preferential transport via albumins in the bloodstream, highly hydrophobic photosensitisers bind more predominantly with lipoproteins, specifically LDLs 146, thus there is potential to use LDL in the targeted delivery of hydrophobic and amphiphilic photosensitisers in pdt.…”

Hypericin fluorescence kinetics in the presence of low density lipoproteins: study on quail CAM assay for topical delivery

“…Properties of Hyp:LDL complex was studied by several authors. Buriankova et al (2011) found that high Hyp:LDL ratios (>30:1) lead to a significant decrease of quantum yield of Hyp fluorescence. The decrease is caused by the formation of non-fluorescent Hyp aggregates inside of LDL molecules and by dynamic selfquenching of Hyp fluorescence.…”

Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds

“…Higher selectivity of PSs for tumor cells can be achieved by combining them with transport agents, which preferentially interact with tumor cells, ensure the selective accumulation of the drug within the diseased tissue, and deliver the desired therapeutic drug concentration to a targeted site in the patient's body. Transport systems commonly used for photosensitizers are polymers, liposomes, oil emulsions, certain metals, some proteins, and carbon-based nanoparticles [5][6][7][8][9][10]. Stable and biocompatible transport systems with a long half-life in the blood are ideal.…”